DD

Darrin Disley

Europe, Cambridgeshire, United Kingdom, Cambridge

Description

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Investor Profile

Darrin Disley has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (60%)
  • Series Unknown (20%)
  • Series A (20%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Genetics
  • Big Data
  • Bioinformatics
  • Life Science
  • Therapeutics
  • Commercial
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Darrin Disley frequently co-invest with?

24 Haymarket
Europe, England, United Kingdom, London
Co-Investments: 2
Boundary Capital Partners LLP
Europe, England, United Kingdom, London
Co-Investments: 1
Origin Capital
Europe, England, United Kingdom, London
Co-Investments: 1
GV
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 1
London Co-Investment Fund
Europe, England, United Kingdom, London
Co-Investments: 1
Angels in MedCity
Europe, England, United Kingdom, London
Co-Investments: 1
IQ Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
Ahren Innovation Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Newable Private Investing
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Darrin Disley often collaborate with?

MM
Europe, England, United Kingdom, London
Shared Deals: 1
RY
Europe, England, United Kingdom, London
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 4

What are some of recent deals done by Darrin Disley?

Mogrify

Cambridge, Cambridgeshire, United Kingdom

Mogrify® will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Big DataBioinformaticsBiotechnologyHealth CareLife ScienceTherapeutics
Series AMay 4, 2021
Amount Raised: $17,000,000
Mogrify

Cambridge, Cambridgeshire, United Kingdom

Mogrify® will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Big DataBioinformaticsBiotechnologyHealth CareLife ScienceTherapeutics
SeedFeb 20, 2019
Amount Raised: $3,700,000
bit.bio

Cambridge, Cambridgeshire, United Kingdom

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

BiotechnologyCommercialHealth Care
SeedNov 16, 2017
Amount Raised: $461,991
Desktop Genetics

London, England, United Kingdom

Desktop Genetics is an international company to help researchers discover and treat the root genetic causes of human disease.

Artificial Intelligence (AI)BiotechnologyGenetics
Series UnknownSep 15, 2015
Amount Raised: $2,148,112
Desktop Genetics

London, England, United Kingdom

Desktop Genetics is an international company to help researchers discover and treat the root genetic causes of human disease.

Artificial Intelligence (AI)BiotechnologyGenetics
SeedAug 27, 2013
Amount Raised: $427,325